Author:
Mahal Katharina,Ahmad Aamir,Sethi Seema,Resch Marcus,Ficner Ralf,Sarkar Fazlul H.,Schobert Rainer,Biersack Bernhard
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine,General Medicine
Reference61 articles.
1. G. Pettit, S. Singh, E. Hamel, C. Lin, D. Alberts, D. Garcia-Kendall, Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4. Experientia 45, 209–211 (1989)
2. C.J. Mooney, G. Nagaiah, P. Fu, J.K. Wasman, M.M. Cooney, P.S. Savvides, J.A. Bokar, A. Dowlati, D. Wang, S.S. Agarwala, A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid 19, 233–240 (2009)
3. G.J. Rustin, G. Shreeves, P.D. Nathan, A. Gaya, T.S. Ganesan, D. Wang, J. Boxall, L. Poupard, D.J. Chaplin, M.R.L. Stratford, J. Balkissoon, M. Zweifel, A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer. Br. J. Cancer 102, 1355–1360 (2010)
4. G.C. Tron, T. Pirali, G. Sorba, F. Pagliai, S. Busacca, A.A. Genazzani, Medicinal chemistry of combretastatin A4: present and future directions. J. Med. Chem. 49, 3033–3044 (2006)
5. S.E. Holwell, P.A. Cooper, M.J. Thompson, G.R. Pettit, L.W. Lippert 3rd, S.W. Martin, M.C. Bibby, Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate. Anticancer Res. 22, 3933–3940 (2002)
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献